Literature DB >> 18207381

A qualitative assessment of injection drug use and harm reduction programmes in Kabul, Afghanistan: 2006-2007.

Catherine S Todd1, Mark A Stibich, M Raza Stanekzai, M Zafar Rasuli, Shairshah Bayan, Saifur Rehman Wardak, Steffanie A Strathdee.   

Abstract

BACKGROUND: The purpose of this paper was to examine the context of injection drug use in Kabul, Afghanistan among injection drug users (IDUs) utilising and not utilising needle and syringe programmes (NSPs).
METHODS: Following identification of themes from eight focus group discussions, free-lists were used for further exploration with both NSP using (n=30) and non-NSP using (n=31) IDUs.
RESULTS: All participants were male, had been injecting for 5 years (mean), and most (95%) had been refugees in the past decade. Main reasons for sharing syringes were convenience and lack of availability and did not vary based on NSP use. Drug users perceived alienation from the community, evidenced by names used for drug users by the community which convey social stigma and moral judgment. Health risks were the principal stated risk associated with drug use, which was mentioned more frequently by NSP users. Harm reduction services available in Kabul are perceived to be insufficient for those in need of services, resulting in under utilisation. The limited scope and distribution of services was frequently cited both as an area for improvement among NSP using IDU or as a reason not to use existing programmes.
CONCLUSIONS: While some positive differences emerged among NSP-using IDU, the current context indicates that both rapid scale-up and increased variety of services, particularly in the realm of addiction treatment, are urgently needed in this setting.

Entities:  

Mesh:

Year:  2008        PMID: 18207381      PMCID: PMC7201369          DOI: 10.1016/j.drugpo.2007.11.022

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  12 in total

1.  Evaluating effectiveness of syringe exchange programmes: current issues and future prospects.

Authors:  F I Bastos; S A Strathdee
Journal:  Soc Sci Med       Date:  2000-12       Impact factor: 4.634

2.  Transitions between routes of heroin administration: a study of Caucasian and Indochinese heroin users in south-western Sydney, Australia.

Authors:  W Swift; L Maher; S Sunjic
Journal:  Addiction       Date:  1999-01       Impact factor: 6.526

3.  Drug use and HIV risk practices of secondary and primary needle exchange users.

Authors:  Dezheng Huo; Susan L Bailey; Ronald C Hershow; Lawrence Ouellet
Journal:  AIDS Educ Prev       Date:  2005-04

4.  Rapid assessment and response studies of injection drug use: knowledge gain, capacity building, and intervention development in a multisite study.

Authors:  Gerry V Stimson; Chris Fitch; Don DesJarlais; Vladimir Poznyak; Theresa Perlis; Edna Oppenheimer; Tim Rhodes
Journal:  Am J Public Health       Date:  2005-12-27       Impact factor: 9.308

5.  Needle exchange and the HIV outbreak among injection drug users in Vancouver, Canada.

Authors:  Evan Wood; Thomas Kerr
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

Review 6.  Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence.

Authors:  Alex Wodak; Annie Cooney
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

7.  Rethinking coverage of needle exchange programs.

Authors:  Dave Burrows
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

8.  Secondary syringe exchange as a model for HIV prevention programs in the Russian Federation.

Authors:  Kevin Irwin; Evgeni Karchevsky; Robert Heimer; Larissa Badrieva
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

9.  Advocacy and coverage of needle exchange programs: results of a comparative study of harm reduction programs in Brazil, Bangladesh, Belarus, Ukraine, Russian Federation, and China.

Authors:  Dave Burrows
Journal:  Cad Saude Publica       Date:  2006-04-05       Impact factor: 1.632

10.  Access and coverage of needle and syringe programmes (NSP) in Central and Eastern Europe and Central Asia.

Authors:  Carmen Aceijas; Matthew Hickman; Martin C Donoghoe; Dave Burrows; Raminta Stuikyte
Journal:  Addiction       Date:  2007-06-12       Impact factor: 6.526

View more
  9 in total

1.  Prevalence and correlates of syphilis and condom use among male injection drug users in four Afghan cities.

Authors:  Catherine S Todd; Abdul Nasir; Mohammad Raza Stanekzai; Abdullah M S Abed; Steffanie A Strathdee; Christian T Bautista; Paul T Scott; Boulos A Botros; Jeffrey Tjaden
Journal:  Sex Transm Dis       Date:  2010-11       Impact factor: 2.830

2.  Opiate use, treatment, and harm reduction in Afghanistan: recent changes and future directions.

Authors:  Catherine S Todd; David Macdonald; Kaveh Khoshnood; G Farooq Mansoor; Mark Eggerman; Catherine Panter-Brick
Journal:  Int J Drug Policy       Date:  2012-06-18

3.  Injection Drug Users' Perceived Barriers to Using Self-Initiated Harm Reduction Strategies.

Authors:  Erin E Bonar; Harold Rosenberg
Journal:  Addict Res Theory       Date:  2014-08-01

4.  Six rapid assessments of alcohol and other substance use in populations displaced by conflict.

Authors:  Nadine Ezard; Edna Oppenheimer; Ann Burton; Marian Schilperoord; David Macdonald; Moruf Adelekan; Abandokoth Sakarati; Mark van Ommeren
Journal:  Confl Health       Date:  2011-02-11       Impact factor: 2.723

5.  Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment.

Authors:  Catherine S Todd; Abdul Nasir; M Raza Stanekzai; Katja Fiekert; M Zafar Rasuli; David Vlahov; Steffanie A Strathdee
Journal:  Harm Reduct J       Date:  2011-08-25

6.  Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.

Authors:  Catherine S Todd; Abdul Nasir; Mohammad Raza Stanekzai; Katja Fiekert; Heather L Sipsma; David Vlahov; Steffanie A Strathdee
Journal:  Harm Reduct J       Date:  2015-10-16

Review 7.  Factors Associated with HIV Risk and Vulnerability Among Injecting Drug Users in Afghanistan: A Narrative Review.

Authors:  Ahmad Shekaib Rasikh
Journal:  HIV AIDS (Auckl)       Date:  2022-07-23

Review 8.  Understanding injecting drug use in Afghanistan: A scoping review.

Authors:  Frishta Nafeh; Sufiat Fusigboye; Bundit Sornpaisarn
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-09-19

Review 9.  Challenges and opportunities for implementation of substance misuse interventions in conflict-affected populations.

Authors:  M Claire Greene; Jeremy C Kane; Kaveh Khoshnood; Peter Ventevogel; Wietse A Tol
Journal:  Harm Reduct J       Date:  2018-11-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.